Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 12—December 2022
Research

Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali

Léa LucianiComments to Author , Nathanaël Lapidus, Abdennour Amroun, Alessandra Falchi, Chanthala Souksakhone, Mayfong Mayxay, Audrey Dubot-Pérès, Paola Mariela Saba Villarroel, Issa Diarra, Ousmane Koita, Pierre Gallian, and Xavier de Lamballerie
Author affiliations: Aix-Marseille Université-IRD 190-Inserm 1207, Marseille, France (L. Luciani, A. Amroun, A. Dubot-Pérès, P.M. Saba Villarroel, I. Diarra, P. Gallian, X. de Lamballerie); Sorbonne Université, Inserm, Saint-Antoine Hospital, Paris, France (N. Lapidus); Université de Corse Pascal Paoli, Corte, France (A. Falchi); Lao Red Cross, Vientiane, Laos (C. Souksakhone); Ministry of Health, Vientiane (M. Mayxay); University of Health Sciences, Vientiane (M. Mayxay); Mahosot Hospital, Vientiane (M. Mayxay, A. Dubot Pérès); University of Oxford, Oxford, UK (M. Mayxay, A. Dubot Pérès); University of Sciences, Bamako, Mali (I. Diarra, O. Koita); Établissement Français du Sang, La Plaine Saint Denis, France (P. Gallian)

Main Article

Table 3

Demographic characteristics of populations in 4 regions of France who had serum samples tested for antibodies against both vaccinia and cowpox viruses in study of orthopoxvirus seroprevalence and infection susceptibility in France, Bolivia, Laos, and Mali*

Characteristics Corsica Midi-Pyrénées PACA Auvergne-Loire Total
M/F ratio 1.00 1.16 1.04 1.53 1.17
Mean year of birth ±SD
 1966 ±12
 1966 ±13
 1967 ±13
 1966 ±13
 1966 ±13
Decade of birth
1940s 14 185 162 77 438 (9.8)
1950s 38 443 371 213 1,065 (23.9)
1960s 59 457 491 228 1,235 (27.8)
1970s 33 308 359 166 866 (19.5)
1980s 21 244 252 106 623 (14.0)
1990s
 3
 101
 70
 47
 221 (5.0)
Total 168 1,738 1,705 837 4,448

*Values are no. participants or no. (%) unless otherwise noted. Percentages were calculated according to a total of 4,448 participants in France who had serum samples tested by using the seroneutralization assay. PACA, Provence Alpes Côte-d’Azur.

Main Article

Page created: October 14, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external